CATO SMS, a global provider of clinical research solutions, announced on Tuesday that it has named Dr Teresa Nunes as its new chief medical officer.

In the new role, Dr Nunes will head the firm's expanding medical services and drug monitoring departments. She will also offer strategic support to her clients in the design and implementation of studies in complex development areas such as oncology, cell and gene therapy, immunology and rare diseases.

Dr Nunes has around 20 years of experience in global clinical research and drug safety. She has served as Vice President and Global Head of Medical Affairs at Premier Research. She has also served at senior medical positions at Vertex Pharmaceuticals, BlueClinical, PRA Health Sciences and Bial.